$RLMD 8-K SEC Filings

Filed On	Filing
08 Sep 2026	8-K: Other Events Dr. Raj S. Pruthi’s employment as Chief Medical Officer – Urology of Relmada Therapeutics, Inc., ended on September 3, 2026.
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Jul 2026	8-K: Regulation FD Disclosure
28 May 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
12 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
20 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
09 Mar 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
15 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
13 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
05 Nov 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
04 Nov 2025	8-K: Regulation FD Disclosure; Other Events
17 Sep 2025	8-K: Regulation FD Disclosure
16 Sep 2025	8-K: Other Events
10 Sep 2025	8-K: Regulation FD Disclosure
02 Sep 2025	8-K: Regulation FD Disclosure
07 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Jul 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
10 Jul 2025	8-K: Termination of a Material Definitive Agreement
18 Jun 2025	8-K: Regulation FD Disclosure
27 May 2025	8-K: Submission of Matters to a Vote of Security Holders

Comments